Cohort Study of Long-term Safety of Upadacitinib for the Treatment of Ulcerative Colitis and Crohn’s Disease in a Real-world Setting in Europe

ENCePP Seal

This study has been awarded the ENCePP seal

Conflicts of interest of investigators

DeclarationofInterests-Annex5-JReutfors

Composition of steering group and observers

EUPAS107124-107878

Signed code of conduct

empty_file.pdf

Signed code of conduct checklist

empty_file.pdf

Signed checklist for study protocols

empty_file.pdf

Data sources

• Data source(s):
  Danish registries (access/analysis)

  National Prescribed Drugs Register / Läkemedelsregistret
• Data source(s), other:
  SWIBREG Sweden, ENEIDA Spain, SMINET Sweden, Swedish national registers Sweden
• Data sources (types):
  Administrative data (e.g. claims)

  Disease registry

  Drug dispensing/prescription data

Use of a Common Data Model (CDM)

• CDM mapping:
  No

Data quality specifications

• Check conformance:
  Unknown
• Check completeness:
  Unknown
• Check stability:
  Unknown
• Check logical consistency:
  Unknown

Data characterisation

• Data characterisation conducted:
  No